go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Reckitt Benckiser Ireland Limited

Reckitt Benckiser Ireland Limited
7 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
Telephone: +353 1 468 9200
Fax: +353 1 468 9299


Summary of Product Characteristics last updated on medicines.ie: 05/07/2011
SPC Hc45 Hydrocortisone Acetate 1% w/w Cream

Table of Contents

  • 1. NAME OF THE MEDICINAL PRODUCT
  • 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
  • 3. PHARMACEUTICAL FORM
  • 4. CLINICAL PARTICULARS
  • 4.1 Therapeutic indications
  • 4.2 Posology and method of administration
  • 4.3 Contraindications
  • 4.4 Special warnings and precautions for use
  • 4.5 Interaction with other medicinal products and other forms of interaction
  • 4.6 Pregnancy and lactation
  • 4.7 Effects on ability to drive and use machines
  • 4.8 Undesirable effects
  • 4.9 Overdose
  • 5. PHARMACOLOGICAL PROPERTIES
  • 5.1 Pharmacodynamic properties
  • 5.2 Pharmacokinetic properties
  • 5.3 Preclinical safety data
  • 6. PHARMACEUTICAL PARTICULARS
  • 6.1 List of excipient(s)
  • 6.2 Incompatibilities
  • 6.3 Shelf life
  • 6.4 Special precautions for storage
  • 6.5 Nature and contents of container
  • 6.6 Special precautions for disposal and other handling
  • 7. MARKETING AUTHORISATION HOLDER
  • 8. MARKETING AUTHORISATION NUMBER(S)
  • 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
  • 10. DATE OF REVISION OF THE TEXT


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Hc45 Hydrocortisone Acetate Cream

(Hydrocortisone acetate 1% w/w)


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Hydrocortisone acetate 1% w/w

Excipients:

Cetostearyl alcohol 7.2% w/w

For full list of excipients, see section 6.1.


Go to top of the page
3. PHARMACEUTICAL FORM

Cream.

White, odourless or almost odourless cream


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Allergic contact dermatitis

Irritant contact dermatitis

Insect bite reactions

Mild to moderate eczema


Go to top of the page
4.2 Posology and method of administration

Adults and children over 10 years: Apply sparingly to a small area, once or twice a day, for a maximum of 7 days.

Do not use in pregnancy or in children under 10 without medical advice.

For topical administration.


Go to top of the page
4.3 Contraindications

Use in the presence of untreated infections of bacterial, viral, tuberculous or fungal origin.

Do not use on the eyes or face, the ano-genital area or on broken or infected skin, including impetigo, cold sores, acne or athlete's foot.

Use in acne rosacea or in perioral dermatoses.


Go to top of the page
4.4 Special warnings and precautions for use

Do not use on the eyes or face, the ano-genital area or on broken or infected skin, including impetigo, cold sores, acne or athlete's foot.

Do not use in pregnancy or in children under 10 without medical advice. If the condition does not improve, consult the doctor.

Continuous application without interruption will result in local atrophy of the skin, striae and superficial vascular dilatation, particularly of the face.

Prolonged use of uninterrupted occlusion or use with extensive occlusive dressings may suppress adrenocortical function.

This product contains ceteostearly alcohol which my cause local skin reactions (e.g. contact dermatitis).


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

Should not be used in pregnancy unless considered essential by the physician.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

None known during the recommended period of treatment.


Go to top of the page
4.9 Overdose

No special antidotes are likely to be required.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Hydrocortisone is a corticosteroid which has anti-inflammatory activity.


Go to top of the page
5.2 Pharmacokinetic properties

Hydrocortisone is a corticosteroid which has anti-inflammatory activity which is thought to result, at least in part from binding with a steroid receptor.

Hydrocortisone decreases inflammation by stabilising cell membranes, preventing the release of destructive enzymes, antagonising histamine and the release of kinins, inhibiting accumulation of macrophages and reducing capillary wall permeability and oedema formation.


Go to top of the page
5.3 Preclinical safety data

Following topical application to most areas of normal skin, only minimal amounts of the drug reach the dermis and subsequently the systemic circulation. Absorption may be markedly increased when the skin has lost its keratin layers and can be increased by inflammation or diseases of the epidermal barrier.

Hydrocortisone is absorbed to a greater degree from scrotum, axilla, eyelid, face and scalp than from the forearm, knee, palm and sole.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipient(s)
White soft paraffin

Liquid Paraffin

Cetomacrogol emulsifying wax (includes cetostearyl alcohol)

Phenoxyethanol

Purified water


Go to top of the page
6.2 Incompatibilities

Not applicable.


Go to top of the page
6.3 Shelf life

3 years


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C.


Go to top of the page
6.5 Nature and contents of container

Internally lacquered, membrane-sealed, collapsible aluminium tube with polypropylene or high density polythene cap containing 15g cream..


Go to top of the page
6.6 Special precautions for disposal and other handling

No special requirements


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Reckitt Benckiser Ireland Ltd.,

7 Riverwalk,

Citywest Business Campus,

Dublin 24


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PA 979/45/1


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

24th September 1996 / 24th September 2001


Go to top of the page
10. DATE OF REVISION OF THE TEXT

June 2011



Link to this document from your website:
http://www.medicines.ie/medicine/12385/SPC/Hc45+Hydrocortisone+Acetate+1++w+w+Cream/

Document Links

 
  Link to this page
  View all medicines
from this company
Print this page
View document history
Bookmark and Share

Legal Categories

 
   Product subject to medical
prescription which may not
be renewed (A)
   Product subject to medical
prescription which may
be renewed (B)
   Product subject to
restricted prescription
(C)
   Supply through
general sale
   Supply through
pharmacy only

Active Ingredients

 
   Hydrocortisone Acetate

  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo